PNA-LNA Clamps for Ultra-Sensitive Mutation Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting low-frequency DNA mutations in liquid biopsy samples, such as those found in cancer patients, are limited by high false positive and false negative rates, particularly when mutant DNA copy levels fall below 20 copies per sample, making it difficult to reliably detect early evidence of mutated ctDNA.
Innovation Solution
A combination of wild-type sequence suppression using PNA or LNA clamps and base-match sensitive luminescence probes is employed to enhance the signal-to-noise ratio, allowing for consistent detection of mutations at frequencies as low as 0.1% relative to wild-type DNA, even when mutant DNA copy levels are below 10 per sample.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional PCR-based genotyping assays or Sanger sequencing are used, then detection sensitivity can reach 2-8%, but they cannot reliably detect mutations below 15% of total DNA due to the large excess of wild type genetic material
Solution Approach 1:
The patent extracts and suppresses the wild type sequence amplification specifically, separating it from the mutant sequence amplification. By using wild type-specific clamp sequences (PNA or LNA) that bind to and inhibit wild type PCR amplification, the method isolates the mutant signal from the overwhelming wild type background, enabling reliable detection at ultra-low frequencies below 0.1%.
Solution Approach 2:
The patent changes the chemical parameters of the amplification system by introducing clamp sequences with different binding properties (PNA or LNA) that specifically target wild type sequences. This parameter change in the amplification chemistry allows selective suppression of wild type amplification while preserving mutant amplification, fundamentally altering the detection sensitivity threshold.
2Measurement precision
If ultra-sensitive next generation sequencing (u-NGS) or Digital PCR (d-PCR) are used, then mutation detection can reach 20-25 copies or 10-12 copies respectively, but false positive and false negative rates increase significantly when mutant DNA copy levels fall below these thresholds
Solution Approach 1:
The patent introduces clamp sequences (PNA or LNA) as intermediary molecules that mediate between the wild type DNA and the PCR amplification process. These clamps act as blocking agents that specifically interfere with wild type amplification without affecting mutant amplification, serving as a chemical mediator to enhance the signal-to-noise ratio and improve both sensitivity and accuracy simultaneously.
Solution Approach 2:
The patent creates a composite amplification system combining standard PCR reagents with clamp sequences (PNA-LNA-DNA hybrids). This composite material approach integrates multiple chemical components with different properties into a unified system that achieves both ultra-sensitive detection and high reliability by leveraging the complementary strengths of each component.
3Measurement precision
If wild type suppression PCR methods are used, then detection sensitivity improves, but significant false positive and false negative events occur at the limits of the low-end range
Solution Approach 1:
The patent applies preliminary suppression action by adding wild type-specific clamp sequences to the PCR reaction mixture before amplification begins. These clamps pre-bind to wild type templates and prevent their amplification, establishing the suppression effect in advance. This preliminary action ensures that when amplification occurs, only mutant sequences are amplified, eliminating false positives and false negatives at low copy numbers.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a robust and reliable method for detecting rare DNA mutations with a signal-to-noise ratio of 10 or more, significantly improving the sensitivity and accuracy of mutation detection in liquid biopsies, enabling earlier detection of clinically relevant changes and potential early cancer screening.
Implementation Method 1
wild-type sequence suppression using PNA or LNA clamps
Implementation Method 2
base-match sensitive luminescence probes is employed to enhance the signal-to-noise ratio
Data Source
AI summary
Compositions and methods are described that provide a technique that reliably and robustly detects DNA mutations at present at concentrations as low as 0.001% relative to corresponding wild type DNA of the same DNA locus. Such compositions and methods are particularly suitable for clinical liquid biopsies, where cells containing diagnostically useful mutations are present in low numbers.